Vieillard, Vincent
Combadière, Béhazine
Tubiana, Roland
Launay, Odile
Pialoux, Gilles
Cotte, Laurent
Girard, Pierre-Marie
Simon, Anne
Dudoit, Yasmine
Reynes, Jacques
Rockstroh, Jürgen
Garcia, Felipe
Gatell, Jose
Devidas, Alain
Yazdanpanah, Yazdan
Weiss, Laurence
Fätkenheuer, Gerd
Autran, Brigitte
Joyeux, Delphine
Gharakhanian, Shahin
Debré, Patrice
Katlama, Christine
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (681137)
Article History
Received: 14 December 2018
Accepted: 26 April 2019
First Online: 3 June 2019
Change Date: 13 August 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: V.V. and P.D. are founders of InnaVirVax and consultants for Minka Tx. B.C. is consultant for Minka Tx. S.G. has been consultant for InnaVirVax. D.J. is Chief Operative Officer of Minka Tx. The remaining authors declare no competing interests.